CERS PEER ANALYSIS

Cerus Corporation — metric-by-metric comparison with peers and the industry median

CERSCerus Corporation

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

CERSIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	CERS	4DX	SN	ONCSM	MEDTR	COH	Ind. Median
P/E	—	—	20.83●	121.43	597.66	24.11	27.09
P/B	9.25	-77.13●	2.51	13.25	1.08	4.30	2.51
EV/EBITDA	539.55	—	9.98●	25.26	10.94	15.11	15.39
P/S	2.81	252.89	2.11	7.60	1.18●	3.53	2.62

Financial Health
Metric	CERS	4DX	SN	ONCSM	MEDTR	COH	Ind. Median
Current Ratio	1.63	6.57●	2.57	2.25	3.58	2.46	3.28
Debt/Equity	144.1%	-22.6%●	62.9%	35.0%	1.0%	22.1%	44.7%
NetDebt/EBITDA	14.23	0.71	1.72	0.42	-1.64●	0.42	0.82

Profitability
Metric	CERS	4DX	SN	ONCSM	MEDTR	COH	Ind. Median
Net Margin	-4.3%	-3,684.6%	10.1%	6.3%	0.2%	14.6%●	-5.7%
ROE	-15.5%	—	12.1%	12.9%	0.2%	18.1%●	-8.6%
ROA	-4.4%	-264.3%	6.1%	8.0%	0.2%	12.4%●	-6.4%
EBITDA Margin	0.5%	-818.8%	25.6%	30.6%●	9.4%	24.0%	5.2%

Growth + Dividend
Metric	CERS	4DX	SN	ONCSM	MEDTR	COH	Ind. Median
Rev. Growth	20.3%	-26.0%	—	39.1%●	6.5%	2.0%	7.4%
NI Growth	—	—	—	—	-62.9%	-6.8%●	16.7%
Div. Yield	—	—	3.5%	0.0%	1.1%	3.6%●	1.1%
Payout	—	—	52.8%	0.0%	656.3%	81.5%	39.0%

Valuation
Metric	CERS	CTKB	CLPT	TCMD	PACB	SIBN	Ind. Median
P/E	—	—	—	35.00	—	—	27.09
P/B	9.25	1.79●	27.41	3.26	201.64	4.25	2.51
EV/EBITDA	539.55	—	—	15.67●	—	—	15.39
P/S	2.81	2.87	12.72	2.07●	2.98	3.69	2.62

Financial Health
Metric	CERS	CTKB	CLPT	TCMD	PACB	SIBN	Ind. Median
Current Ratio	1.63	4.69	5.79	4.24	5.65	9.99●	3.28
Debt/Equity	144.1%	11.1%	337.5%	7.0%	29,729.0%	4.1%●	44.7%
NetDebt/EBITDA	14.23	10.20	-1.18	-1.44	-4.01●	22.93	0.82

Profitability
Metric	CERS	CTKB	CLPT	TCMD	PACB	SIBN	Ind. Median
Net Margin	-4.3%	-36.2%	-71.6%	5.9%●	-80.3%	-8.1%	-5.7%
ROE	-15.5%	-20.9%	-149.7%	9.6%●	-273.6%	-9.6%	-8.6%
ROA	-4.4%	-15.9%	-47.1%	7.3%●	-15.6%	-7.1%	-6.4%
EBITDA Margin	0.5%	-10.8%	-58.2%	12.1%●	-66.6%	-2.9%	5.2%

Growth + Dividend
Metric	CERS	CTKB	CLPT	TCMD	PACB	SIBN	Ind. Median
Rev. Growth	20.3%	3.6%	26.0%●	17.2%	5.0%	16.8%	7.4%
NI Growth	—	—	—	25.3%	—	—	16.7%
Div. Yield	—	—	—	—	—	—	1.1%
Payout	—	—	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CERS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.